These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16024828)

  • 1. Fluid overload contributing to heart failure.
    Shotan A; Dacca S; Shochat M; Kazatsker M; Blondheim DS; Meisel S
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii24-7. PubMed ID: 16024828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of diuretics in the treatment of chronic heart failure].
    Düsing R
    Herz; 1990 Jun; 15(3):185-9. PubMed ID: 2198219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G; Klapholz M
    Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High output heart failure.
    Mehta PA; Dubrey SW
    QJM; 2009 Apr; 102(4):235-41. PubMed ID: 18990720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fluid volume regulation in health and disease.
    Abraham WT; Schrier RW
    Adv Intern Med; 1994; 39():23-47. PubMed ID: 8140955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of volume overload in acute heart failure syndromes.
    Chen HH; Schrier RW
    Am J Med; 2006 Dec; 119(12 Suppl 1):S11-6. PubMed ID: 17113395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congestive heart failure: new paradigms and therapeutic targets.
    Arnaout MS; Alam SE
    J Med Liban; 2003; 51(3):169-75. PubMed ID: 15707079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation.
    Gotloib L; Fudin R; Yakubovich M; Vienken J
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii32-6. PubMed ID: 16024831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME; Dunlap ME
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):87-92. PubMed ID: 18090676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of renal replacement therapy in acute decompensated heart failure.
    Udani SM; Murray PT
    Semin Dial; 2009; 22(2):173-9. PubMed ID: 19426424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2007 Nov; 74(10):1466-75. PubMed ID: 17720144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.